In vivo light dosimetry for motexafin lu
✍
Andreea Dimofte; Timothy C. Zhu; Stephen M. Hahn; Robert A. Lustig
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 365 KB
## Abstract ## Background and Objectives To measure the fluence at tissue surface for patients in our Phase II clinical trial of motexafin lutetium (MLu)‐mediated chest wall photodynamic therapy for recurrent breast carcinoma and to compare it to the calculated irradiance. ## Study Design/Materia